News Column

Protea Biosciences Group, Inc. Files SEC Form 5, Annual Statement of Changes in Beneficial Ownership of Securities (Feb. 13, 2014)

March 3, 2014

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Protea Biosciences Group, Inc. (Form 5) was posted on February 13, 2014.

The SIC code for this company is 2834, Pharmaceutical Preparations.

There was one document filed with this form. The SEC file number is 0001144204-14-008740.

The contact information for this company is 955 HARTMAN RUN ROAD, MORGANTOWN WV 26507, 304 292-2226.

Our editors provided additional information about Form 5: Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the Commission a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The Annual Statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person's relationship to the company and on purchases and sales of such equity securities.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see:

Keywords for this news article include: Pharmaceutical Preparations, Chemicals, Chemistry, SEC Filing, Biotechnology Company, Protea Biosciences Group Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Pharma Business Week

Story Tools